Rovetia

How to Screen for Developmental Delay in Toddlers?

pediatrician developmental-screening assessment
Quick answer: Screen at 9, 18, and 30 months using validated tools like ASQ-3, plus autism screening at 18 and 24 months. Refer immediately if concerns arise.

Developmental delay affects approximately 17 percent of children in the United States, yet many cases are not identified until school age. Early detection through systematic screening at well-child visits allows timely intervention during the period of greatest brain plasticity. The American Academy of Pediatrics recommends a two-part approach combining ongoing developmental surveillance with formal screening at specific ages using validated tools.

Step 1: Conduct Developmental Surveillance at Every Visit

Developmental surveillance is a continuous, flexible process that occurs at every well-child visit through early childhood. According to the CDC, surveillance involves five components: eliciting and addressing parental concerns, maintaining a developmental history, observing the child's behavior and interactions, identifying risk factors, and documenting findings.

During surveillance:

Formal developmental screening uses standardized, validated tools with established sensitivity and specificity. The AAP recommends general developmental screening at 9, 18, and 30 months of age. Autism-specific screening is recommended at 18 and 24 months.

Commonly used validated tools include:

The choice of screening tool is left to the clinician, but tools must be validated for the population being screened. Screening is intended to identify risk, not to diagnose.

Step 3: Administer Screening Tools Efficiently

The CDC's Pediatric Developmental Screening Flowchart outlines a practical workflow. Parents complete the screening tool in the waiting room before the visit. Clinical staff score and review the tool answers. Based on results, the provider determines whether concerns exist.

Tips for efficient administration:

Step 4: Interpret Screening Results

Screening results fall into two categories: no concerns or concerns identified.

When no concerns are identified:

When concerns are identified:

Step 5: Avoid a Wait-and-See Approach

The AAP explicitly recommends against adopting a wait-and-see approach when developmental concerns are identified. Research shows that children with developmental delays benefit most from early intervention, and waiting can result in lost opportunities for optimal outcomes.

When screening results are concerning or when parents or providers have ongoing concerns:

Red Flags Requiring Immediate Action

Certain findings warrant urgent referral regardless of screening results:

Common Questions

What if a child misses a scheduled screening visit?

Screen at the next available visit. The AAP recommends that if a child misses a routine well-child visit when screening would typically occur, screening should be done at the next visit. Do not wait for the next scheduled age interval.

Can screening tools be used in languages other than English?

Many validated screening tools have been translated and validated in other languages. Check with the tool developer for available translations. When validated translations are not available, use interpreter services and document the limitation. Avoid using non-validated translations.

What is the difference between surveillance and screening?

Surveillance is an ongoing, flexible process of observing and asking about development at every visit. Screening is a formal, standardized assessment using validated tools at specific ages. Both are necessary. Research shows that children who receive both surveillance and screening together are more likely to receive early intervention than those who receive either alone.

How do I discuss concerning results with parents?

Approach the conversation with empathy and clarity. Explain that screening identifies children who may benefit from additional support, not that the child has a diagnosis. Emphasize that early intervention can make a significant difference. Provide written information about next steps and local resources. Offer to answer questions and schedule a follow-up call after referrals are made.

Protocol Summary

How Rovetia Helps

Rovetia supports developmental screening by organizing all patient information into a searchable timeline. Pediatricians can track screening results across visits, monitor milestone attainment, and quickly identify children who may have missed recommended screening intervals. AI-assisted documentation from voice input or uploaded reports reduces administrative burden, allowing more time for direct patient interaction. The structured timeline ensures that surveillance findings, screening results, and referral outcomes are never lost between visits, supporting continuity of care from infancy through early childhood.

Sources

Less management, more attention

Convert scattered medical information into structured, searchable, time-saving clinical intelligence.

Get started FREE